While the general population lifetime risk of ovarian cancer is low at 1.4% [1], women at high-risk of developing the disease due to their inheritance of a germline BRCA1 and BRCA2 mutation have an average cumulative risk of between 40% to 75% and 11% to 34%, respectively [2–5]. This evidence concerns the gene BRCA2 and ovarian cancer.